Teleflex receives FDA clearance for the Wattson Temporary Pacing Guidewire 

June 7, 2023 – Teleflex announced it will feature the Wattson® Temporary Pacing Guidewire – the first commercially available bipolar temporary pacing guidewire designed specifically for use during TAVR and BAV. 

Featuring a simple design to create procedural efficiencies, the Wattson® Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during TAVR or BAV procedures. The device offers a procedural alternative designed to help avoid a range of complications, steps, and costs associated with traditional right ventricular pacing. From its flexible distal pigtail shape to its multiple electrode, bipolar design, the Wattson® Temporary Pacing Guidewire is engineered to help reduce the risk of ventricular perforation while providing confidence in capture during rapid pacing. 

“This technology enables us to provide physicians with a new tool specifically engineered to address unmet clinical needs frequently encountered during TAVR or BAV procedures,” said Jake Newman, President of The Americas at Teleflex. “The Wattson® Temporary Pacing Guidewire reflects our focus on purposeful innovation and commitment to providing more options to further simplify minimalist TAVR and other structural procedures.” 

The Wattson® Temporary Pacing Guidewire will enter a limited market release phase, with full market release anticipated later this year. 

Learn More 

safe online pharmacy for viagra cheap kamagra oral jelly online